“Stem Cells: Platform Technology for Rare CNS Diseases”

In Clinical Development, Featured on App, Market Access, Orphan Drug Congress by Freya Smale

Ann Tsukamoto of Stem Cells   joined us at World Orphan Drug Congress USA 2015 to present about ‘Platform Technology for Rare CNS  Diseases’ 
Download her presentation now to learn about:

  • HuCNS-SC: First Class in Biologic
  • HuCNS-SC Pre-Clinical Observations Reflected in Early Clinical Results
  • Gene Modified Human Neural Stem Cells 
…and much more!
Get your copy here!
To find out more about  platform technology for rare CNS diseases , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington DC.